UNSPSC 51384607: Celecoxib

This classification denotes a cyclooxygenase inhibitor with the molecular formula C17H14F3N3O2S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier JCX84Q7J1L, chemically known as benzenesulfonamide, 4-(5-(4-methylphenyl)-3-(trifluoromethyl)-1h-pyrazol-1-yl)- but generally known as celecoxib, which bears US NIH Compound Identifier 2662. European Medicines Agency schedules Celecoxib in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB01143MIG.

UNSPSC 51384607 Celecoxib is a Commodity code that maps to pharmaceutical products, but the recent state and local opportunity posted under this code does not align with celecoxib procurement. Seminole County, Florida posted IFB 60459723LAS in June 2026 seeking naloxone and safe drug deactivation systems — opioid-overdose reversal agents and controlled-substance disposal equipment — rather than celecoxib, a nonsteroidal anti-inflammatory drug. The mismatch suggests either a coding error in the county's procurement system or a broad tagging of pharmaceutical-adjacent health supplies under this commodity code. State and local health departments, counties, and community health authorities are the typical issuing bodies for naloxone and drug-disposal systems procurement, driven by public-health mandates and overdose-prevention initiatives.

Seminole County's solicitation represents the only recent documented activity under this code in the source. The county sought 1,900 units of naloxone and 800 safe drug deactivation systems annually through competitive bidding, with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida, and a response deadline of July 26, 2023. The contract carries a two-year initial term with a one-year renewal option, includes FEMA funding compliance requirements, and mandates standard certifications such as E-Verify and drug-free workplace status. Given the mismatch between the code's nominal scope (celecoxib) and actual procurement activity (naloxone and drug deactivation), this code shows limited actionable signal for business development targeting celecoxib-specific opportunities in state and local government.